wxbcvanpu
2021-02-03
什么意思呢
ROCE Insights For Bionano Genomics<blockquote>ROCE对Bionano基因组学的见解</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
1
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":314045955,"tweetId":"314045955","gmtCreate":1612281975977,"gmtModify":1703759960180,"author":{"id":3566212400811103,"idStr":"3566212400811103","authorId":3566212400811103,"authorIdStr":"3566212400811103","name":"wxbcvanpu","avatar":"https://static.tigerbbs.com/4b24368ca481cf01f78abb3439ce4272","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>什么意思呢</p></body></html>","htmlText":"<html><head></head><body><p>什么意思呢</p></body></html>","text":"什么意思呢","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/314045955","repostId":2108398627,"repostType":2,"repost":{"id":"2108398627","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1612284397,"share":"https://www.laohu8.com/m/news/2108398627?lang=zh_CN&edition=full","pubTime":"2021-02-03 00:46","market":"hk","language":"en","title":"ROCE Insights For Bionano Genomics<blockquote>ROCE对Bionano基因组学的见解</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2108398627","media":"Benzinga","summary":"During Q3, Bionano Genomics's (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.","content":"<p><html><body>During Q3, <strong><a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a></strong>'s (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.</p><p><blockquote><html><body>第三季度期间，<strong><a href=\"https://laohu8.com/S/BNGO\">生物纳米基因组学</a></strong>（纳斯达克：BNGO）报告销售额总计220万美元。尽管盈利增长37.55%，但该公司仍亏损1023万美元。Bionano Genomics在第二季度实现了118万美元的收入，但报告的收益显示亏损743万美元。</body></html></blockquote></p><p> <h3>What Is ROCE?</h3> Changes in earnings and sales indicate shifts in Bionano Genomics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Bionano Genomics posted an ROCE of -0.7%.</p><p><blockquote><h3>什么是ROCE？</h3>收益和销售额的变化表明Bionano Genomics的已用资本回报率（衡量企业所用资本的年度税前利润）的变化。一般来说，较高的ROCE表明公司成功增长，并且是未来每股收益较高的标志。第三季度，Bionano Genomics的ROCE为-0.7%。</blockquote></p><p> It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.</p><p><blockquote>重要的是要记住，ROCE评估过去的表现，而不是用作预测工具。这是衡量公司近期业绩的一个很好的指标，但有几个因素可能会影响不久的将来的收益和销售额。</blockquote></p><p> Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.</p><p><blockquote>所用资本回报率是衡量效率的重要指标，也是比较同行业公司时的有用工具。相对较高的ROCE表明公司可能产生的利润可以再投资于更多资本，从而为股东带来更高的回报和不断增长的每股收益。</blockquote></p><p> For Bionano Genomics, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.</p><p><blockquote>对于Bionano Genomics来说，资本回报率表明当前的资产数量实际上可能无法帮助公司实现更高的回报，这是许多投资者在做出长期财务决策时会考虑的一个因素。</blockquote></p><p> <h3>Q3 Earnings Recap</h3> Bionano Genomics reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.05/share.</p><p><blockquote><h3>第三季度收益回顾</h3>Bionano Genomics公布第三季度每股收益为-0.08美元/股，未达到分析师预测的-0.05美元/股。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ROCE Insights For Bionano Genomics<blockquote>ROCE对Bionano基因组学的见解</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nROCE Insights For Bionano Genomics<blockquote>ROCE对Bionano基因组学的见解</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2021-02-03 00:46</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><body>During Q3, <strong><a href=\"https://laohu8.com/S/BNGO\">Bionano Genomics</a></strong>'s (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.</p><p><blockquote><html><body>第三季度期间，<strong><a href=\"https://laohu8.com/S/BNGO\">生物纳米基因组学</a></strong>（纳斯达克：BNGO）报告销售额总计220万美元。尽管盈利增长37.55%，但该公司仍亏损1023万美元。Bionano Genomics在第二季度实现了118万美元的收入，但报告的收益显示亏损743万美元。</body></html></blockquote></p><p> <h3>What Is ROCE?</h3> Changes in earnings and sales indicate shifts in Bionano Genomics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Bionano Genomics posted an ROCE of -0.7%.</p><p><blockquote><h3>什么是ROCE？</h3>收益和销售额的变化表明Bionano Genomics的已用资本回报率（衡量企业所用资本的年度税前利润）的变化。一般来说，较高的ROCE表明公司成功增长，并且是未来每股收益较高的标志。第三季度，Bionano Genomics的ROCE为-0.7%。</blockquote></p><p> It is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.</p><p><blockquote>重要的是要记住，ROCE评估过去的表现，而不是用作预测工具。这是衡量公司近期业绩的一个很好的指标，但有几个因素可能会影响不久的将来的收益和销售额。</blockquote></p><p> Return on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.</p><p><blockquote>所用资本回报率是衡量效率的重要指标，也是比较同行业公司时的有用工具。相对较高的ROCE表明公司可能产生的利润可以再投资于更多资本，从而为股东带来更高的回报和不断增长的每股收益。</blockquote></p><p> For Bionano Genomics, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.</p><p><blockquote>对于Bionano Genomics来说，资本回报率表明当前的资产数量实际上可能无法帮助公司实现更高的回报，这是许多投资者在做出长期财务决策时会考虑的一个因素。</blockquote></p><p> <h3>Q3 Earnings Recap</h3> Bionano Genomics reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.05/share.</p><p><blockquote><h3>第三季度收益回顾</h3>Bionano Genomics公布第三季度每股收益为-0.08美元/股，未达到分析师预测的-0.05美元/股。</blockquote></p><p> </body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"source_url":"https://www.benzinga.com/node/19445351","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108398627","content_text":"During Q3, Bionano Genomics's (NASDAQ:BNGO) reported sales totaled $2.20 million. Despite a 37.55% in earnings, the company posted a loss of $10.23 million. Bionano Genomics collected $1.18 million in revenue during Q2, but reported earnings showed a $7.43 million loss.\nWhat Is ROCE?\nChanges in earnings and sales indicate shifts in Bionano Genomics's Return on Capital Employed, a measure of yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth of a company and is a sign of higher earnings per share in the future. In Q3, Bionano Genomics posted an ROCE of -0.7%.\nIt is important to keep in mind ROCE evaluates past performance and is not used as a predictive tool. It is a good measure of a company's recent performance, but several factors could affect earnings and sales in the near future.\nReturn on Capital Employed is an important measurement of efficiency and a useful tool when comparing companies that operate in the same industry. A relatively high ROCE indicates a company may be generating profits that can be reinvested into more capital, leading to higher returns and growing EPS for shareholders.\nFor Bionano Genomics, the return on capital employed ratio shows the current amount of assets may not actually be helping the company achieve higher returns, a note many investors will take into account when making long-term financial decisions.\nQ3 Earnings Recap\nBionano Genomics reported Q3 earnings per share at $-0.08/share, which did not meet analyst predictions of $-0.05/share.","news_type":1,"symbols_score_info":{"BNGO":1}},"isVote":1,"tweetType":1,"viewCount":926,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/314045955"}
精彩评论